Ashkon Software



CNLMU - CB Pharma Acquisition Corp.

CB Pharma Acquisition Corp. logo CB Pharma Acquisition Corp. (CNLMU) is a blank-check company that was formed for the purpose of acquiring one or more businesses or assets in the healthcare industry. The company's focus is on identifying opportunities in the pharmaceuticals, biotechnology, medical devices, and healthcare services sectors.

As a blank-check company, CB Pharma Acquisition Corp. has no operating history or revenue, and its future prospects will depend on the success of its acquisition strategy. The company has a team of experienced healthcare industry executives and advisors who will be responsible for identifying and evaluating potential acquisition targets.

CB Pharma Acquisition Corp. was founded in 2020 and is based in New York City. The company went public in December 2020, raising approximately $150 million in its initial public offering (IPO). As of my knowledge cutoff of September 2021, there is no further information available about the company's acquisition plans or potential targets.

CB Pharma Acquisition Corp. is listed on the NASDAQ stock exchange under the ticker symbol CNLMU, which includes one share of Class A common stock and one-half of a redeemable warrant to purchase one share of Class A common stock. Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share. The warrants are exercisable beginning on the later of 30 days after the completion of the company's initial business combination or 12 months from the closing




Copyright © 2000-2023, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer